230 related articles for article (PubMed ID: 12218099)
1. Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection.
Vaillant F; Blyth K; Andrew L; Neil JC; Cameron ER
J Immunol; 2002 Sep; 169(6):2866-74. PubMed ID: 12218099
[TBL] [Abstract][Full Text] [Related]
2. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.
Nawijn MC; Ferreira R; Dingjan GM; Kahre O; Drabek D; Karis A; Grosveld F; Hendriks RW
J Immunol; 2001 Jul; 167(2):715-23. PubMed ID: 11441075
[TBL] [Abstract][Full Text] [Related]
3. A critical role for CD2 in both thymic selection events and mature T cell function.
Sasada T; Reinherz EL
J Immunol; 2001 Feb; 166(4):2394-403. PubMed ID: 11160298
[TBL] [Abstract][Full Text] [Related]
4. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells.
Hayashi K; Natsume W; Watanabe T; Abe N; Iwai N; Okada H; Ito Y; Asano M; Iwakura Y; Habu S; Takahama Y; Satake M
J Immunol; 2000 Dec; 165(12):6816-24. PubMed ID: 11120804
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
[TBL] [Abstract][Full Text] [Related]
6. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
Xi H; Kersh GJ
J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
[TBL] [Abstract][Full Text] [Related]
7. Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes.
Ehlers M; Laule-Kilian K; Petter M; Aldrian CJ; Grueter B; Würch A; Yoshida N; Watanabe T; Satake M; Steimle V
J Immunol; 2003 Oct; 171(7):3594-604. PubMed ID: 14500656
[TBL] [Abstract][Full Text] [Related]
8. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
[TBL] [Abstract][Full Text] [Related]
9. Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.
Lacorazza HD; Tucek-Szabo C; Vasović LV; Remus K; Nikolich-Zugich J
J Immunol; 2001 Mar; 166(5):3184-93. PubMed ID: 11207271
[TBL] [Abstract][Full Text] [Related]
10. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
Barndt R; Dai MF; Zhuang Y
J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
[TBL] [Abstract][Full Text] [Related]
11. Enforced expression of Spi-B reverses T lineage commitment and blocks beta-selection.
Lefebvre JM; Haks MC; Carleton MO; Rhodes M; Sinnathamby G; Simon MC; Eisenlohr LC; Garrett-Sinha LA; Wiest DL
J Immunol; 2005 May; 174(10):6184-94. PubMed ID: 15879115
[TBL] [Abstract][Full Text] [Related]
12. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
[TBL] [Abstract][Full Text] [Related]
13. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
Urban JA; Winandy S
J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
[TBL] [Abstract][Full Text] [Related]
14. Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion.
Staal FJ; Weerkamp F; Baert MR; van den Burg CM; van Noort M; de Haas EF; van Dongen JJ
J Immunol; 2004 Jan; 172(2):1099-108. PubMed ID: 14707084
[TBL] [Abstract][Full Text] [Related]
15. Deranged early T cell development in immunodeficient strains of nonobese diabetic mice.
Yui MA; Rothenberg EV
J Immunol; 2004 Nov; 173(9):5381-91. PubMed ID: 15494484
[TBL] [Abstract][Full Text] [Related]
16. The osmoprotective function of the NFAT5 transcription factor in T cell development and activation.
Trama J; Go WY; Ho SN
J Immunol; 2002 Nov; 169(10):5477-88. PubMed ID: 12421923
[TBL] [Abstract][Full Text] [Related]
17. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development.
Williams KL; Zullo AJ; Kaplan MH; Brutkiewicz RR; Deppmann CD; Vinson C; Taparowsky EJ
J Immunol; 2003 Mar; 170(5):2417-26. PubMed ID: 12594265
[TBL] [Abstract][Full Text] [Related]
18. The quantity of TCR signal determines positive selection and lineage commitment of T cells.
Watanabe N; Arase H; Onodera M; Ohashi PS; Saito T
J Immunol; 2000 Dec; 165(11):6252-61. PubMed ID: 11086060
[TBL] [Abstract][Full Text] [Related]
19. A molecular marker for thymocyte-positive selection: selection of CD4 single-positive thymocytes with shorter TCRB CDR3 during T cell development.
Yassai M; Ammon K; Goverman J; Marrack P; Naumov Y; Gorski J
J Immunol; 2002 Apr; 168(8):3801-7. PubMed ID: 11937532
[TBL] [Abstract][Full Text] [Related]
20. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
